A recently identified gene expression signature of EMT markers containing the transcription factor Slug was found present in samples from many publicly available cancer gene expression datasets of multiple cancer types except leukemia. We also found many of these genes co-expressed in human cancer xenografted cells, but not in mouse stroma cells, suggesting that the signature is largely produced by cancer cells undergoing some type of EMT. Here we report that a partial signature consisting of a subset of the co-expressed genes of the full signature, including at least Slug (SNAI2), collagens COL1A1, COL1A2, COL3A1, COL6A3 and genes DCN and LUM, is also present in leukemia, in which case it is also strongly associated with the chemokine CXCL12 (aka SDF1). The same subset of co-expressed genes is also strongly present even in normal samples in a tissue-specific manner, with lowest expression in brain tissues and highest expression in reproductive system tissues. The full signature, with prominent presence of COL11A1, THBS2 and INHBA appears to be triggered in solid cancers particularly when cancer cells encounter adipocytes.
Introduction
A gene expression signature consisting of a set of genes many of which are epithelialmesenchymal transition (EMT) markers including the EMT-inducing transcription factor Slug (SNAI2) was recently identified [1] . The signature is present in publicly available datasets of all solid cancer types that we tried. These genes are coordinately expressed at various levels, but are significantly overexpressed only in samples that have exceeded a particular stage, specific to each cancer type. A list of the top 64 genes of the signature is shown, for reference, in Table 1 . We also found [2] that many of the genes of the signature, including α-SMA, are expressed by the cancer cells themselves in vivo, at least in one xenograft model of neuroblastoma that we tried [3] , confirming that cancer cells have undergone a mesenchymal transition (the term EMT may not be accurate in this case, as the same signature is also present in cancers, such as neuroblastoma, that are not, strictly speaking, epithelial). We refer to this multi-cancer signature as the "cancer mesenchymal transition signature." It is characterized by a prominent presence of co-expressed genes COL11A1, THBS2, INHBA.
Consistent with this hypothesis, the signature is not found present in either leukemia or normal tissues. We hypothesized, however, that a subset of these genes may still remain co-expressed with Slug even in nonsolid cancers. Such findings would shed light on the more general biological mechanism of Slug-based mesenchymal transition when it happens without the full myofibroblast-like transdifferentiation that occurs in invasive tumors (in which case the transformed cancer cells may be confused with stromal cancer associated fibroblasts).
Results
Here we report that further computational analysis in gene expression datasets of leukemia samples, as well as of normal human body multi-tissue datasets, revealed that a subset of the cancer mesenchymal transition signature, consisting at least of Slug, collagens COL1A1, COL1A2, COL3A1, COL6A3 and genes DCN and LUM remain strongly co-expressed in all cases. These results were reached by simply comparing the pairwise associations of the 64 genes of the full signature of Table 1 in various datasets. Furthermore, ranking the genes in terms of their association (such as mutual information) with SNAI2 in each data set consistently identifies the above seven genes close to the top of the list.
To demonstrate the coexpression of the above seven genes, we generated corresponding heat maps including only these genes.
The heat map of the TCGA leukemia dataset is shown in the Supplementary Figure available at www.ee.columbia.edu/~anastas/np/heatmap.leukemia.7genes.pdf We observed that the same signature is also strongly associated in leukemia with the chemokine CXCL12 (aka SDF1), providing related biological insights.
The heat map of the 504 normal samples from the "human body index" GSE7307 dataset is shown in the Supplementary Figure available at www.ee.columbia.edu/~anastas/np/heatmap.normal.7genes.pdf Remarkably, there is strong tissue specificity associated with the presence of the Slug-based EMT signature. At one end of the spectrum where ( Table 2 , left side), the signature appears absent in brain tissues. At the other end of the spectrum (Table 2 , right side), the signature appears present in higher amounts in reproductive system tissues. This phenomenon is fully demonstrated in the color-coded table of all 504 samples that appears as Supplementary Table available at www.ee.columbia.edu/~anastas/np/snai2tissuetype.xlsx Because EMT is known to generate cells with properties of stem cells [4] , these results are compatible with the notion that, among normal human body tissues, the brain contains highly differentiated cells with the least amount of "stemness," while the reproductive system contains cells with the highest amount of stemness. The lack of stemness in the normal state of brain cells is also consistent with our recent finding that the absence of the full Slug-based cancer mesenchymal transition signature in glioblastoma is associated with prolonged time to recurrence following treatment [5] . Glioblastoma samples reveal coexpression of most of the genes of Table 1 , but COL11A1 is not as strongly coexpressed.
We have also hypothesized [2, 3] that the full Slug-based cancer mesenchymal transition signature is triggered in solid cancers following contextual microenvironmental interactions when cancer cells encounter adipocytes. In that case, COL11A1 can serve as a reliable proxy of the full signature. 
